Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1

Journal of Cardiovascular Electrophysiology

Volumn 27, Issue 10, 2016, Pages 1220-1229

  Polejaeva, Irina A ^a   Ranjan, Ravi ^c,d   Davies, Christopher J ^a   Regouski, Misha ^a   Hall, Justin ^a   Olsen, Aaron L ^a   Meng, Qinggang ^a   Rutigliano, Heloisa M ^a   Dosdall, Derek J ^c   Angel, Nathan A ^c   Sachse, Frank B ^d,e   Seidel, Thomas ^e   Thomas, Aaron J ^a   Stott, Rusty ^a   Panter, Kip E ^b   Lee, Pamela M ^f   Van Wettere, Arnaud J ^a   Stevens, John R ^a   Wang, Zhongde ^a   Macleod, Rob S ^c,e   Marrouche, Nassir F ^c   White, Kenneth L ^a   more..

^a UTAH STATE UNIVERSITY   (United States)

^b USDA ARS POISONOUS PLANT RESEARCH LABORATORY   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d University of Utah   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

atrial fibrillation; fibrosis; genetics; TGF 1 transgenic goat model

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIAL FIBRILLATION; CAPRINE MODEL; CARDIAC MUSCLE CELL; CELL NUCLEUS TRANSPLANTATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; EMBRYO; FEMALE; FETUS; GENE OVEREXPRESSION; HEART; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; MORPHOMETRICS; NONHUMAN; P WAVE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SOMATIC CELL; TRANSGENE; TRANSGENIC GOAT; WILD TYPE;

EID: 84991082934     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.13049     Document Type: Article

References (46)

1. Andrade J, Khairy P, Dobrev D, Nattel S: The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms. Circ Res 2014;114:1453-1468.
2. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, Lellouche N, Knecht S, Wright M, Nault I, Miyazaki S, Scavee C, Clementy J, Haissaguerre M, Jais P: Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011;57:160-166.
3. Winkle RA, Mead RH, Engel G, Patrawala RA: Long-term results of atrial fibrillation ablation: The importance of all initial ablation failures undergoing a repeat ablation. Am Heart J 2011;162:193-200.
4. Khan R, Sheppard R: Fibrosis in heart disease: Understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006;118:10-24.
5. Tan AY, Zimetbaum P: Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol 2011;57:625-629.
6. Li D, Fareh S, Leung TK, Nattel S: Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999;100:87-95.
7. Guerra JM, Everett TH, Lee KW, Wilson E, Olgin JE: Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 2006;114:110-118.
8. Verheule S, Sato T, Everett Tt, Engle SK, Otten D, Rubart-von der Lohe M, Nakajima HO, Nakajima H, Field LJ, Olgin JE: Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 2004;94:1458-1465.
9. Lee KW, Everett THt, Rahmutula D, Guerra JM, Wilson E, Ding C, Olgin JE: Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 2006;114:1703-1712.
10. Rahmutula D, Marcus GM, Wilson EE, Ding CH, Xiao Y, Paquet AC, Barbeau R, Barczak AJ, Erle DJ, Olgin JE: Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-beta1. Cardiovasc Res 2013;99:769-779.
11. Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C, Munzel T: Atrial fibrosis and atrial fibrillation: The role of the TGF-beta1 signaling pathway. Int J Cardiol 2010;143:405-413.
12. Polyakova V, Miyagawa S, Szalay Z, Risteli J, Kostin S: Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 2008;12:189-208.
13. Nishida K, Michael G, Dobrev D, Nattel S: Animal models for atrial fibrillation: Clinical insights and scientific opportunities. Europace 2010;12:160-172.
14. Olgin JE, Verheule S: Transgenic and knockout mouse models of atrial arrhythmias. Cardiovasc Res 2002;54:280-286.
15. Nakajima H, Nakajima HO, Salcher O, Dittie AS, Dembowsky K, Jing S, Field LJ: Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res 2000;86:571-579.
16. Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allessie M, Borgers M: Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol 2001;33:2083-2094.
17. Verheule S, Tuyls E, Gharaviri A, Hulsmans S, van Hunnik A, Kuiper M, Serroyen J, Zeemering S, Kuijpers NH, Schotten U: Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ Arrhythm Electrophysiol 2013;6:202-211.
18. Biernacka A, Frangogiannis NG: Aging and cardiac fibrosis. Aging Dis 2011;2:158-173.
19. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM: Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: Implications for development of atrial fibrillation. Eur Heart J 2006;27:3045-3056.
20. Anter E, Jessup M, Callans DJ: Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation 2009;119:2516-2525.
21. Keefer CL, Baldassarre H, Keyston R, Wang B, Bhatia B, Bilodeau AS, Zhou JF, Leduc M, Downey BR, Lazaris A, Karatzas CN: Generation of dwarf goat (Capra hircus) clones following nuclear transfer with transfected and nontransfected fetal fibroblasts and in vitro-matured oocytes. Biol Reprod 2001;64:849-856.
22. Pawshe CH, Totey SM, Jain SK: A comparison of three methods of recovery of goat oocytes for in vitro maturation and feritilization. Theriogenology 1994;42:117-125.
23. Reggio BC, James AN, Green HL, Gavin WG, Behboodi E, Echelard Y, Godke RA: Cloned transgenic offspring resulting from somatic cell nuclear transfer in the goat: Oocytes derived from both follicle-stimulating hormone-stimulated and nonstimulated abattoir-derived ovaries. Biol Reprod 2001;65:1528-1533.
24. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001;25:402-408.
25. Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS, Moses BL: Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993;7:247-252.
26. Leroux AA, Farnir F, Moonen ML, Sandersen CF, Deleuze S, Amory H: Repeatability, variability and reference values of pulsed wave Doppler echocardiographic measurements in healthy Saanen goats. BMC Vet Res 2012;8:190.
27. Savio-Galimberti E, Frank J, Inoue M, Goldhaber JI, Cannell MB, Bridge JHB, Sachse FB: Novel features of the rabbit transverse tubular system revealed by quantitative analysis of three-dimensional reconstructions from confocal images. Biophys J 2008;95:2053-2062.
28. Schwab BC, Seemann G, Lasher RA, Torres NS, Wulfers EM, Arp M, Carruth ED, Bridge JHB, Sachse FB: Quantitative analysis of cardiac tissue including fibroblasts using three-dimensional confocal microscopy and image reconstruction: Towards a basis for electrophysiological modeling. IEEE Trans Med Imaging 2013;32:862-872.
29. Bancroft J, Gamble M: Theory and Practice of Histological Techniques. London, UK: Churchill Livingstone, 2008.
30. Bujak M, Frangogiannis NG: The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-195.
31. Pellman J, Lyon RC, Sheikh F: Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol 2010;48:461-467.
32. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E: Cardiac fibrosis in patients with atrial fibrillation: Mechanisms and clinical implications. J Am Coll Cardiol 2015;66:943-959.
33. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
34. Verheule S, Wilson E, Everett Tt, Shanbhag S, Golden C, Olgin J: Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 2003;107:2615-2622.
35. Burstein B, Nattel S: Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-809.
36. Hanna N, Cardin S, Leung TK, Nattel S: Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 2004;63:236-244.
37. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY: Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011;58:2225-2232.
38. Spach MS: Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation. Circ Res 2007;101:743-745.
39. Burstein B, Libby E, Calderone A, Nattel S: Differential behaviors of atrial versus ventricular fibroblasts: A potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 2008;117:1630-1641.
40. Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ: P wave indices: Current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol 2009;2:72-79.
41. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A, Kondoh N, Minamino T, Hoki N: Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991;83:162-169.
42. Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, Crijns HJ: Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: Longitudinal dissociation. Circ Arrhythm Electrophysiol 2010;3:606-615.
43. Eckstein J, Zeemering S, Linz D, Maesen B, Verheule S, van Hunnik A, Crijns H, Allessie MA, Schotten U: Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation evidence from simultaneous endo-epicardial high-density activation mapping. Circ Arrhythm Electrophysiol 2013;6:334-341.
44. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1-76.
45. Wu SH, Jiang WF, Gu J, Zhao L, Wang YL, Liu YG, Zhou L, Gu JN, Xu K, Liu X: Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: A systematic review and meta-analysis. Int J Cardiol 2013;169:35-43.
46. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM: Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012;60:628-636.